Cargando…
In Situ Forming Injectable Hydrogel For Encapsulation Of Nanoiguratimod And Sustained Release Of Therapeutics
BACKGROUND: Iguratimod (IGUR) is a novel disease-modifying antirheumatic drug used for treating rheumatoid arthritis (RA). To improve its bioavailability and to alleviate gastrointestinal side effects, we changed the formulation into nanoiguratimod-loaded hydrogel (NanoIGUR-loaded hydrogel) composit...
Autores principales: | Ma, Zhenzhen, Tao, Cheng, Sun, Lin, Qi, Shengbei, Le, Yuan, Wang, Jiexin, Li, Changhong, Liu, Xiangyuan, Zhang, Jianjun, Zhao, Jinxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6847989/ https://www.ncbi.nlm.nih.gov/pubmed/31806967 http://dx.doi.org/10.2147/IJN.S214507 |
Ejemplares similares
-
MMP-responsive in situ forming hydrogel loaded with doxorubicin-encapsulated biodegradable micelles for local chemotherapy of oral squamous cell carcinoma
por: Li, Wei, et al.
Publicado: (2019) -
Sustained release of therapeutic gene by injectable hydrogel for hepatocellular carcinoma
por: Xu, Shuangta, et al.
Publicado: (2023) -
Advances in Injectable In Situ-Forming Hydrogels for Intratumoral Treatment
por: Shin, Gi Ru, et al.
Publicado: (2021) -
In Situ Forming Injectable Thermoresponsive Hydrogels
for Controlled Delivery of Biomacromolecules
por: Dutta, Kingshuk, et al.
Publicado: (2020) -
Injectable Thermosensitive Hydrogels for a Sustained Release of Iron Nanochelators
por: Park, Seung Hun, et al.
Publicado: (2022)